shared a post on LinkedIn:
“We’re thrilled to count Université Libre de Bruxelles (ULB) among GENIAL’s research partners!
As a leading academic institution, ULB brings expertise in biomedical research, data science, and clinical insights that are essential to GENIAL’s mission: improving the detection and understanding of alcohol-related liver cancer (ALD-HCC).
Together, we’re advancing science and shaping the future of personalized medicine across Europe.
Explore more about ULB.
Learn more.”
